Published in Ann Rheum Dis on October 15, 2013
Study to Prevent Cartilage Damage Following Acute Knee Injury. | NCT00332254
Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol (2014) 1.15
Osteoarthritis joint pain: the cytokine connection. Cytokine (2014) 0.92
Differences in glutamate receptors and inflammatory cell numbers are associated with the resolution of pain in human rotator cuff tendinopathy. Arthritis Res Ther (2015) 0.86
Analgesic, anti-inflammatory, and chondroprotective activities of Cryptolepis buchanani extract: in vitro and in vivo studies. Biomed Res Int (2014) 0.85
Coupled cell networks are target cells of inflammation, which can spread between different body organs and develop into systemic chronic inflammation. J Inflamm (Lond) (2015) 0.79
Gait analysis methods for rodent models of arthritic disorders: reviews and recommendations. Osteoarthritis Cartilage (2016) 0.78
Deletion of P58(IPK), the Cellular Inhibitor of the Protein Kinases PKR and PERK, Causes Bone Changes and Joint Degeneration in Mice. Front Endocrinol (Lausanne) (2014) 0.76
High plasma glutamate levels are associated with poor functional outcome in acute ischemic stroke. Cell Mol Neurobiol (2014) 0.76
The Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence. Front Physiol (2016) 0.75
Transmission pathways and mediators as the basis for clinical pharmacology of pain. Expert Rev Clin Pharmacol (2016) 0.75
Metabolic signatures of T-cells and macrophages in rheumatoid arthritis. Curr Opin Immunol (2017) 0.75
One aptamer, two functions: the full-length aptamer inhibits AMPA receptors, while the short one inhibits both AMPA and kainate receptors. RNA Dis (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res (2004) 25.98
Rheumatoid arthritis. Lancet (2001) 6.14
Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med (1998) 3.20
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage (2012) 2.62
Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) (2004) 2.33
Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum (2003) 2.15
Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2009) 2.03
IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol (1990) 1.82
Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage (2007) 1.57
Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum (2008) 1.53
Pharmaceutical therapy for osteoarthritis. PM R (2012) 1.52
The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis (1988) 1.35
Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol (2009) 1.35
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage (2012) 1.30
Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. J Bone Miner Res (2005) 1.27
Amino acid release into the knee joint: key role in nociception and inflammation. Pain (2000) 1.21
Angiogenesis in osteoarthritis. Curr Opin Rheumatol (2008) 1.21
Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. Mol Endocrinol (2011) 1.20
Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes. J Bone Miner Res (2011) 1.19
Current understanding of rheumatoid arthritis therapy. Clin Pharmacol Ther (2012) 1.18
The ossicles of the semilunar cartilages of rodents. Anat Rec (1949) 1.14
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther (2011) 1.12
Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol (2004) 1.09
Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther (2011) 1.08
Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis (2011) 1.07
Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J (2006) 1.07
A novel method for convenient assessment of arthritic pain in voluntarily walking rats. Neurosci Lett (2001) 1.06
Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther (2012) 1.04
Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol (2000) 1.01
Peripheral calcium-permeable AMPA receptors regulate chronic inflammatory pain in mice. J Clin Invest (2011) 1.00
The efficacy of intra-articular ketamine for postoperative analgesia in outpatient arthroscopic surgery. Arthroscopy (2004) 0.97
Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors. Arthritis Rheum (2007) 0.97
Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis. Arthritis Res Ther (2005) 0.94
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann Rheum Dis (2004) 0.90
Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol (2003) 0.90
The role of glutamate in the regulation of bone mass and architecture. J Musculoskelet Neuronal Interact (2008) 0.90
Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate. Eur J Pharmacol (2008) 0.89
Amelioration of rat antigen-induced arthritis by liposomally conjugated methotrexate is accompanied by down-regulation of cytokine mRNA expression. Rheumatology (Oxford) (2001) 0.89
A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes. Am J Physiol Regul Integr Comp Physiol (2009) 0.88
Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci U S A (2001) 0.87
Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats. Behav Brain Res (2008) 0.86
Mechanical loading modulates glutamate receptor subunit expression in bone. Bone (2005) 0.86
The N-methyl-d-aspartic acid receptor antagonist memantine ameliorates and delays the development of arthritis by enhancing regulatory T cells. Neurosignals (2011) 0.86
Substance P and glutamate receptor antagonists improve the anti-arthritic actions of dexamethasone in rats. Br J Pharmacol (2010) 0.85
Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int (2005) 0.85
In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. Am J Vet Res (2010) 0.83
Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint. Tissue Cell (2005) 0.83
Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis. Arthritis Res Ther (2011) 0.82
Glutamate signaling in bone. Front Endocrinol (Lausanne) (2012) 0.82
Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression. Osteoarthritis Cartilage (2009) 0.82
The glutamatergic N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the joint contribute to the induction, but not maintenance, of arthritic pain in rats. Neurosci Lett (2003) 0.82
Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro. Eur J Pharmacol (2006) 0.80
Injectable medications for osteoarthritis. PM R (2012) 0.80
Increased concentrations of neuro-excitatory amino acids in rat anterior cruciate ligament-transected knee joint dialysates: a microdialysis study. J Orthop Res (2005) 0.80
Possible involvement of glutamatergic signaling machineries in pathophysiology of rheumatoid arthritis. J Pharmacol Sci (2011) 0.79
Release of endogenous glutamate by AMPA receptors expressed in cultured rat costal chondrocytes. Biol Pharm Bull (2005) 0.79
Human Pharmacokinetics of the Neuroprotective Agent NBQX. Am J Ther (1994) 0.76